Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.

Cardioversion can rapidly and effectively restore sinus rhythm in patients with persistent atrial fibrillation. Since 2011 dabigatran has been available as an alternative to warfarin to prevent thromboembolic events in patients with non-valvular atrial fibrillation undergoing cardioversion. We studi...

Full description

Bibliographic Details
Main Authors: Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, Gunnar Hilmar Gislason
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4625957?pdf=render

Internet

http://europepmc.org/articles/PMC4625957?pdf=render

Similar Items